Even though the general population lifetime risk of ovarian cancer is only approximately 1.4%, individuals at high-risk of developing the disease due to harboring a germline BRCA1 and BRCA2 mutation have an average cumulative risk of between 40% to 75% and 11% to 34%, respectively (Mavaddat et al., 2013). This evidence concerns the gene BRCA1 and ovarian cancer.